<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(7)</volume><submitter>Imberti JF</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The incidence of infections and death in patients implanted with cardiac implantable electronic devices (CIEDs) is not fully known yet.&lt;h4>Aim&lt;/h4>To describe the incidence of CIED-related infection and death, and their potential predictors in a contemporary cohort of CIED patients.&lt;h4>Methods&lt;/h4>All consecutive patients implanted with a CIED at our institution were prospectively enrolled. Follow-up visits were performed 2 weeks after CIED implantation for all patients, and then every 6 months for implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy (CRT) patients and every 12 months for pacemaker (PM) patients. The adjudication of CIED-related infections was performed by two independent investigators and potential disagreement was resolved by </pubmed_abstract><journal>Journal of clinical medicine</journal><pagination>2599</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10095352</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices.</pubmed_title><pmcid>PMC10095352</pmcid><pubmed_authors>Gerra L</pubmed_authors><pubmed_authors>Bonini N</pubmed_authors><pubmed_authors>Imberti JF</pubmed_authors><pubmed_authors>Turco V</pubmed_authors><pubmed_authors>Fontanesi R</pubmed_authors><pubmed_authors>Mei DA</pubmed_authors><pubmed_authors>Vitolo M</pubmed_authors><pubmed_authors>Boriani G</pubmed_authors><pubmed_authors>Casali E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices.</name><description>&lt;h4>Background&lt;/h4>The incidence of infections and death in patients implanted with cardiac implantable electronic devices (CIEDs) is not fully known yet.&lt;h4>Aim&lt;/h4>To describe the incidence of CIED-related infection and death, and their potential predictors in a contemporary cohort of CIED patients.&lt;h4>Methods&lt;/h4>All consecutive patients implanted with a CIED at our institution were prospectively enrolled. Follow-up visits were performed 2 weeks after CIED implantation for all patients, and then every 6 months for implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy (CRT) patients and every 12 months for pacemaker (PM) patients. The adjudication of CIED-related infections was performed by two independent investigators and potential disagreement was resolved by </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T20:17:20.954Z</modification><creation>2025-02-18T23:40:38.5Z</creation></dates><accession>S-EPMC10095352</accession><cross_references><pubmed>37048682</pubmed><doi>10.3390/jcm12072599</doi></cross_references></HashMap>